Nectar Lifesciences' Baddi facility receives European cGMP approval for cephalosporin

Nectar Lifesciences Ltd (Neclife) has received second European cGMP (current good manufacturing practices) approval for its cephalosporin finished dosage forms (FDF) manufacturing facility in Baddi, Himachal Pradesh.
 
Nectar Lifesciences has received cGMP compliance certification for both oral & injectables cephalosporins followed by the successful inspection by the Portugal authority - National Authority of Medicines and Health Products, INFARMED, in July 2013.  The INFARMED certificate is accepted by all EU health authorities and authorities of several other countries.
 
This approval, which will facilitate exports to the lucrative generic drug markets of Europe, opens up lot of opportunities for contract manufacturing for Neclife for European customers. The company is also expecting to receive US FDA approval very soon.